# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Sep 27, 2022

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2022-09-27
- Accepted by EDGAR: Sep 27, 2022, 20:25 ET
- Period: 2022-09-23
- Accession: 0001193125-22-252180
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312522252180/d404270d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312522252180/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312522252180/d404270d8k.htm

Filed Sep 27, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-252180. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.